Loading...
The role of factor Xa inhibitors in venous thromboembolism treatment
Three factor Xa inhibitors have been studied in the treatment of venous thromboembolism, both for acute therapy and as extended therapy to prevent recurrent events. Rivaroxaban, apixaban, and edoxaban have all proven to be effective in Phase III clinical trials for this indication when compared to c...
Saved in:
| Published in: | Vasc Health Risk Manag |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4321604/ https://ncbi.nlm.nih.gov/pubmed/25673997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S39726 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|